Cancer BiologybioRxivPreprint
The EphB2-MYC Axis is a Major Determinant of Barrett's Pathobiology and a Therapeutic Vulnerability in Esophageal Cancer
S. Venkitachalam, D. Babu, D. Ravillah…·K. Guda
This study identifies the EphB2-MYC axis as a key driver of Barrett's Esophagus progression to esophageal adenocarcinoma and a potential therapeutic target.
DOI 10.1101/2021.05.13.444044